Urinary markers of nucleic acid oxidation and long-term mortality of newly diagnosed type 2 diabetic patients

Diabetes Care

Volumn 34, Issue 12, 2011, Pages 2594-2596

  Broedbaek, Kasper ^a,b   Siersma, Volkert ^c   Henriksen, Trine ^a,b   Weimann, Allan ^a,b   Petersen, Morten ^a,b   Andersen, Jon T ^a,b   Jimenez Solem, Espen ^a,b   Stovgaard, Elisabeth S ^a,b   Hansen, Lars J ^c   Henriksen, Jan Erik ^d   Bonnema, Steen J ^d   De Fine Olivarius, Niels ^c   Poulsen, Henrik E ^a,b,e  

^a Rigshospitalet   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; 8 HYDROXYGUANOSINE; 8 OXO 7 HYDRODEOXYGUANOSINE; 8-HYDROXYGUANOSINE; 8-OXO-7-HYDRODEOXYGUANOSINE; BIOLOGICAL MARKER; DEOXYGUANOSINE; DRUG DERIVATIVE; GUANOSINE; RNA;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEIC ACID ANALYSIS; PERIPHERAL NEUROPATHY; PREDICTION; RETINOPATHY; RISK FACTOR; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINARY EXCRETION; DENMARK; DNA DAMAGE; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; URINE;

ADULT; BIOLOGICAL MARKERS; DENMARK; DEOXYGUANOSINE; DIABETES MELLITUS, TYPE 2; DNA DAMAGE; GUANOSINE; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA;

EID: 84858132328     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1620     Document Type: Article

References (11)

1. Piconi L, Quagliaro L, Ceriello A. Oxidative stress in diabetes. Clin Chem Lab Med 2003;41:1144-1149 (Pubitemid 37265692)
2. Matheson A, Willcox MD, Flanagan J, Walsh BJ. Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev 2010;26:150-171
3. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-1625 (Pubitemid 40770750)
4. Calcutt NA, Cooper ME, Kern TS, Schmidt AM. Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Nat Rev Drug Discov 2009;8:417-429
5. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 2003;26:1589-1596
6. Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet 2008;371:1800-1809 (Pubitemid 351697956)
7. Broedbaek K, Weimann A, Stovgaard ES, Poulsen HE. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a biomarker in type 2 diabetes. Free Radic Biol Med 2011;51:1473-1479
8. Olivarius NF, Beck-Nielsen H, Andreasen AH, Hørder M, Pedersen PA. Randomised controlled trial of structured personal care of type 2 diabetesmellitus. BMJ 2001;323:970-975 (Pubitemid 33016046)
9. Henriksen T, Hillestrøm PR, Poulsen HE, Weimann A. Automated method for the direct analysis of 8-oxo-guanosine and 8-oxo-2′- deoxyguanosine in human urine using ultraperformance liquid chromatography and tandem mass spectrometry. Free Radic Biol Med 2009;47:629-635
10. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006;53:441-449 (Pubitemid 44816920)
11. Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull 1999;46:354-357 (Pubitemid 29439149)